| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PTGX | Protagonist Therapeutics, Inc | Liu David Y | Chief R&D Strategy Officer | Nov 16, 2022 | Option Exercise | $2.31 | 100,479 | 231,802 | 167,590 | Nov 17, 2022, 06:24 PM | |
| PTGX | Protagonist Therapeutics, Inc | Liu David Y | Chief Scientific Officer | Feb 28, 2022 | Option Exercise | $24.28 | 2,119 | 51,449 | 66,538 | Mar 02, 2022, 08:38 PM | |
| PTGX | Protagonist Therapeutics, Inc | Liu David Y | Chief Scientific Officer | Aug 17, 2021 | Option Exercise | $0.87 | 10,000 | 8,700 | 73,033 | Aug 19, 2021, 05:49 PM | |
| PTGX | Protagonist Therapeutics, Inc | Liu David Y | Chief Scientific Officer | Aug 17, 2021 | Sale | $47.56 | 14,779 | 702,889 | 58,254 | Aug 19, 2021, 05:49 PM | |
| PTGX | Protagonist Therapeutics, Inc | Liu David Y | Chief Scientific Officer | Aug 06, 2019 | Sale | $8.85 | 3,395 | 30,044 | 49,802 | Aug 08, 2019, 06:17 PM | |
| PTGX | Protagonist Therapeutics, Inc | Liu David Y | Chief Scientific Officer | Mar 01, 2019 | Sale | $8.03 | 810 | 6,504 | 51,197 | Mar 04, 2019, 06:35 PM | |
| PTGX | Protagonist Therapeutics, Inc | Liu David Y | Chief Scientific Officer | Feb 06, 2019 | Sale | $7.74 | 3,821 | 29,562 | 37,007 | Feb 08, 2019, 05:30 PM | |
| PTGX | Protagonist Therapeutics, Inc | Liu David Y | Chief Scientific Officer | Mar 12, 2018 | Option Exercise | $4.21 | 3,500 | 14,735 | 18,528 | Mar 13, 2018, 04:48 PM | |
| PTGX | Protagonist Therapeutics, Inc | Liu David Y | Chief Scientific Officer | Mar 12, 2018 | Sale | $21.29 | 3,500 | 74,500 | 15,028 | Mar 13, 2018, 04:48 PM | |
| PTGX | Protagonist Therapeutics, Inc | Liu David Y | Chief Scientific Officer | Mar 02, 2018 | Sale | $20.00 | 875 | 17,500 | 13,322 | Mar 02, 2018, 07:17 PM | |
| PTGX | Protagonist Therapeutics, Inc | Liu David Y | Chief Scientific Officer | Mar 02, 2018 | Option Exercise | $1.89 | 875 | 1,654 | 14,197 | Mar 02, 2018, 07:17 PM | |
| PTGX | Protagonist Therapeutics, Inc | Liu David Y | Chief Scientific Officer | Jan 16, 2018 | Option Exercise | $1.89 | 875 | 1,654 | 4,697 | Jan 17, 2018, 04:34 PM | |
| PTGX | Protagonist Therapeutics, Inc | Liu David Y | Chief Scientific Officer | Jan 16, 2018 | Sale | $20.00 | 875 | 17,500 | 3,822 | Jan 17, 2018, 04:34 PM | |
| PTGX | Protagonist Therapeutics, Inc | Liu David Y | Chief Scientific Officer | Dec 18, 2017 | Option Exercise | $1.89 | 875 | 1,654 | 4,697 | Dec 20, 2017, 09:13 PM | |
| PTGX | Protagonist Therapeutics, Inc | Liu David Y | Chief Scientific Officer | Dec 18, 2017 | Sale | $20.00 | 875 | 17,500 | 3,822 | Dec 20, 2017, 09:13 PM | |
| PTGX | Protagonist Therapeutics, Inc | Liu David Y | Chief Scientific Officer | Nov 30, 2017 | Option Exercise | $1.89 | 875 | 1,654 | 4,697 | Dec 01, 2017, 06:56 PM | |
| PTGX | Protagonist Therapeutics, Inc | Liu David Y | Chief Scientific Officer | Nov 30, 2017 | Sale | $20.00 | 875 | 17,500 | 3,822 | Dec 01, 2017, 06:56 PM | |
| PTGX | Protagonist Therapeutics, Inc | Liu David Y | Chief Scientific Officer | Nov 13, 2017 | Option Exercise | $3.05 | 7,000 | 21,350 | 7,322 | Nov 15, 2017, 07:14 PM | |
| PTGX | Protagonist Therapeutics, Inc | Liu David Y | Chief Scientific Officer | Nov 13, 2017 | Sale | $16.97 | 7,000 | 118,761 | 3,822 | Nov 15, 2017, 07:14 PM | |
| PTGX | Protagonist Therapeutics, Inc | Liu David Y | Chief Scientific Officer | Aug 28, 2017 | Sale | $15.00 | 3,500 | 52,500 | 2,000 | Aug 29, 2017, 07:48 PM | |
| PTGX | Protagonist Therapeutics, Inc | Liu David Y | Chief Scientific Officer | Aug 28, 2017 | Option Exercise | $4.21 | 3,500 | 14,735 | 5,500 | Aug 29, 2017, 07:48 PM | |
| PTGX | Protagonist Therapeutics, Inc | Liu David Y | Chief Scientific Officer | Jul 10, 2017 | Option Exercise | $1.89 | 3,500 | 6,615 | 5,500 | Jul 12, 2017, 05:55 PM | |
| PTGX | Protagonist Therapeutics, Inc | Liu David Y | Chief Scientific Officer | Jul 10, 2017 | Sale | $12.68 | 3,500 | 44,380 | 2,000 | Jul 12, 2017, 05:55 PM |
Menu